Shanghai Fudan-zhangjiang Bio-pharmaceutical Co., Ltd.

This study is testing a light-based therapy to reduce the appearance of port-wine birthmarks. Adults aged 18-75 will receive either the active light treatment or a placebo treatment in cycles. The main goals are to find the safest and most effective light dose and to see how well…

This is the first time researchers are testing the experimental drug FZ-AD004 in people. The study aims to find a safe and tolerable dose for patients with advanced solid tumors that have spread or cannot be surgically removed. Researchers will also gather early information on wh…

This is the first study in people to test a new drug called FZ-AD005. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early signs that it might help shrink tumors in patients with advanced cancers, particularly certai…